Silent heart disease in patients with sleep apnea-hypopnea syndrome: Usefulness of the myocardial performance index;Disfunción miocárdica silente en pacientes con síndrome de apneas-hipopneas durante el sueño. Valor del índice de rendimiento miocárdico

Archivos de Bronconeumologia

Volumn 44, Issue 8, 2008, Pages 418-423

  Moro, José A ^a,c   Almenar, Luis ^a   Fernández Fabrellas, Estrella ^b   Ponce, Silvia ^b   Blanquer, Rafael ^b   Salvador, Antonio ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^c NONE   (Spain)

Author keywords

Doppler echocardiography; Hypertrophy; Left ventricular dysfunction; Sleep apnea hypopnea syndrome

Indexed keywords

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART PERFORMANCE; HEART RATE VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; SILENT MYOCARDIAL INFARCTION; SLEEP APNEA SYNDROME;

FEMALE; HEART DISEASES; HEART FUNCTION TESTS; HUMANS; MALE; MIDDLE AGED; SLEEP APNEA SYNDROMES;

EID: 51349109243     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1157/13125379     Document Type: Article

References (32)

1. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328:1230-5.
2. Duran J, Esnaola S, Rubio R, Iztueta A. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med. 2001;163:685-9.
3. Consenso Nacional sobre el síndrome de apneas-hipopneas del sueño. Grupo Español de Sueño. Arch Bronconeumol. 2005;41 Supl 4:51-67.
4. Newman AB, Nieto FJ, Guidry U, Lind BK, Redline S, Pickering TG, et al. Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol 2001;154:50-9.
5. Bradley TD, Floras J. Sleep apnea and heart failure: Part I: obstructive sleep apnea. Circulation 2003;107:1671-8.
6. Terán J, Alonso ML, Cordero J, Ayuela JM, Monserrat JM. Síndrome de apneas-hipopneas durante el sueño y corazón. Rev Esp Cardiol. 2006;59:718-24.
7. Montserrat JM, Ferrer M, Hernández L, Farre R, Vilagut G, Navajas D, et al. Effectiveness of CPAP treatment in daytime function in sleep apnea syndrome: a randomized controlled study with an optimized placebo. Am J Respir Crit Care Med. 2001;164:608-13.
8. Shamsuzzaman AS, Gersh BJ, Somers VK. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA. 2003; 290:1906-14.
9. Lind L, Andren B, Ärnlöv. The Doppler-derived myocardial performance index is determined by both left ventricular systolic and diastolic function as well as by afterload and left ventricular mass. Echocardiography. 2005;22:211-6.
10. Tei C, Ling LH, Hodge DO, Bailey KR, Oh JK, Rodeheffer RJ, et al. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function -a study in normal and dilated cardiomyopathy. J Cardiol. 1995; 26:357-66.
11. Tei C. New non-invasive index for combined systolic and diastolic ventricular function. J Cardiol. 1995;26:135-6.
12. Dingli K, Coleman EL, Vennelle M, Finch SP, Wraith PK, Mackay TW, et al. Evaluation of a portable device for diagnosing the sleep apnoea/hypopnoea syndrome. Eur Respir J. 2003;21:253-9.
13. Chiner E, Arriero J, Signes-Costa J, Marco J, Fuentes I. Validación de la versión española del test de somnolencia Epworth en pacientes con síndrome de apnea de sueño. Arch Bronconeumol. 1999;35:422-7.
14. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. American Society of Echocardiography's Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography; European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7:79-108.
15. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450-8.
16. Tei C, Nishimura RA, Seward JB, Tajik AJ. Noninvasive Doppler-derived myocardial performance index: correlation with simultaneous measurements of cardiac catheterization measurements. J Am Soc Echocardiogr. 1997;10:169-78.
17. Tei C, Dujardin KS, Hodge DO, Bailey KR, McGoon MD, Tajik AJ, et al. Doppler echocardiographic index for assessment of global right ventricular function. J Am Soc Echocardiogr. 1996;9:838-47.
18. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-52.
19. Lauer MS, Anderson KM, Levy D. Separate and joint influences of obesity and mild hypertension on left ventricular mass and geometry: the Framingham Heart Study. J Am Coll Cardiol. 1992;19:130-4.
20. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier Nieto F, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study.Am J Respir Crit Care Med. 2001;163:19-25.
21. Hedner J, Ejnell H, Caidahl K. Left ventricular hypertrophy independent of hypertension in patients with obstructive sleep apnoea. J Hypertens. 1990;8:941-6.
22. Laaban JP, Pascal-Sebaoun S, Bloch E, Orvoën-Frija E, Oppert JM, Huchon G. Left ventricular systolic dysfunction in patients with obstructive sleep apnea syndrome. Chest. 2002;122:1133-8.
23. Fung JW, Li TS, Choy DK, Yip GW, Ko FW, Sanderson JE, et al. Severe obstructive sleep apnea is associated with left ventricular diastolic dysfunction. Chest. 2002;121:422-9.
24. Shivalkar B, Van de Heyning C, Kerremans M, Rinkevich D, Verbraecken J, De Backer W, et al. Obstructive sleep apnea syndrome: more insights on structural and functional cardiac alterations, and the effects of treatment with continuous positive airway pressure. J Am Coll Cardiol. 2006;47:1433-9.
25. Arias MA, García-Rio F, Alonso-Fernández A, Sánchez AM. Síndromes de apneas-hipopneas durante el sueño e insuficiencia cardíaca. Rev Esp Cardiol. 2007;60:415-27.
26. Arias MA, García-Rio F. Disfunción ventricular en el síndrome de apnea-hipopnea obstructiva durante el sueño: en búsqueda de la relevancia clínica. Rev Esp Cardiol. 2007;60:569-72.
27. Dursunoglu N, Dursunoglu D, Ozkurt S, Gür S, Ozalp G, Evyapan F. Effects of CPAP on right ventricular myocardial performance index in obstructive sleep apnea patients without hypertension. Respir Res. 2006;7:22.
28. Dursunoglu N, Dursunoglu D, Ozkurt S, Kuru O, Gür S, Kiter G, et al. Effects of CPAP on left ventricular structure and myocardial performance index in male patients with obstructive sleep apnoea. Sleep Med. 2007;8:51-9.
29. Hogg K, Swedberg K, McMurray J. Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol. 2004;43:317-27.
30. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al. Guías de práctica clínica sobre el diagnóstico y tratamiento de la insuficiencia cardíaca crónica. Versión resumida (actualización 2005). Rev Esp Cardiol. 2005;58:1062-92.
31. Martínez MA, Gómez R, Gil T, Soler JJ, Bernácer B, Román P. Trastornos respiratorios durante el sueño en pacientes con hipertensión arterial de difícil control. Arch Bronconeumol. 2006;42:14-20.
32. Vgonzas AN, Bixler EO, Tan TL, Kantner D, Martín LF, Kales A. Obesity without apnea is associated with daytime sleepiness. Arch Intern Med. 1998;158:1333-7.